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Summary
Aim: To determine whether an association exists between
the different plasma lipoprotein constituents and the pre-
valence of lenticular opacities in dyslipidaemic subjects.
Methods: Adult patients  (n = 115) of both genders were
included if their fasting total serum cholesterol concen-
trations exceeded the 95th percentile of normal or their
serum low-density lipoprotein (LDL) : high-density
lipoprotein (HDL) ratios exceeded 5. Patients were
excluded if they suffered from any condition known to
cause, or predispose them to, elevated lipoprotein levels
or lenticular opacification. Lenticular changes were
assessed by means of a slit-lamp through the fully dilat-
ed pupil.
Results: An extremely strong association (p < 0.0001) was
found to exist between HDL cholesterol levels and the
development of lens opacities. Below an HDL-C level of
1.5 mmol/l subjects had a seven-fold higher calculated
probability of falling in the lens opacity subgroup than
those with HDL-C levels above 1.5 mmol/l [odds ratio =
7.33 (95% CI = 2.06–26.10; p = 0.001)]. An equally strong
association was found between high (>5) LDL:HDL
ratios and the development of lens opacities (p < 0.0003).
The risk of falling into the cataract subgroup if the indi-
vidual’s LDL:HDL ratio exceeded 5 was 2.35 (95% CI =
1.09–5.04; p = 0.014).
Conclusions: This study strongly suggests that an
association exists between low levels of HDL cholesterol
and high LDL:HDL ratios on one hand and the develop-
ment of adult lens opacification on the other.
Cardiovasc J South Afr 2003; 14: 60–64. www.cvjsa.co.za
Lens opacification and cardiovascular disease are two of the
main causes of morbidity in humans worldwide.1,2 Lens
opacity, leading eventually to cataract is responsible for an
estimated 40% of the 42 million cases of blindness in the
world.3 Heart disease on the other hand is the single greatest
cause of death in developed countries.4 The relationship
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between cholesterol and cardiovascular heart disease is well
documented. The relationship between cholesterol and lens
opacity is, however, far less well appreciated. Dyslipidaemia
can be defined as abnormal serum lipid levels containing one
or more of the following elements: raised total serum cho-
lesterol, raised serum triglycerides, reduced serum high-
density lipoprotein cholesterol (HDL-C) levels or a low-
density lipoprotein (LDL) : high-density lipoprotein (HDL)
ratio greater than 5.
It has recently been shown that dyslipidaemic patients
develop cortical lens opacities more frequently and at an ear-
lier age than the normal population, and that cortical lens
opacities should be regarded as one of the most common,
and hence reliable, clinical signs of dyslipidaemia.5 The next
logical question is whether total serum cholesterol or any of
the different fractions that make up the lipogram (i.e. LDL-
cholesterol, HDL-cholesterol, triglycerides, LDL:HDL
ratio) can be associated with the high prevalence of lens
opacification in the dyslipidaemic patient population. This
study was designed to examine that question.
Methods
One hundred and fifteen individuals with proven dyslipi-
daemia were subjected to both a general physical examina-
tion by a specialist physician and a slit-lamp ophthalmic
examination of the fully dilated eye by an ophthalmologist.
In order to obtain a study group with maximum homogene-
ity and minimum risk of other cataractogenic factors, only
patients meeting the following criteria were enrolled:
Inclusion criteria: Adults of both genders, 18 to 60 years
of age with a serum total cholesterol level > 5.2 mmol/l
(exceeding the 95th percentile of normal) and an LDL:HDL
ratio > 5 were included in the study.
Exclusion criteria: Pregnant or lactating females, subjects
with severe hypertension (diastolic blood pressure > 115
mm Hg), history of cardiovascular disease, diabetes mellitus
(defined as fasting blood glucose > 7.8 mmol/l), hypothy-
roidism (thyroid stimulating hormone > 7.5 mU/l), any
malignant tumour, significant renal impairment (serum crea-
tinine >170 µmol/l), history of pancreatitis, gallbladder dis-
ease including cholelithiasis, gastro-intestinal disease or
patients who were known to be HIV antibody positive were
excluded.
Fasting blood samples were obtained from each individ-
ual on three occasions over a period of four weeks. Patients
were only included in the study if their lipoprotein variables
adhered to the inclusion criteria on each of the three visits.
Lenticular opacities were classified as cortical (water
clefts, vacuoles, flakes, wedges and spokes), nuclear (normal
colour, pale yellow, yellow, dark yellow or brown) or sub-
capsular (anterior or posterior). Both a specialist physician
and an ophthalmologist examined all the patients.
Statistical analysis
Subjects were identified as belonging to one of two groups,
those with clear lenses and those with opacities. The signif-
icance of the difference in mean HDL-cholesterol level
between the groups was tested by the Student’s t-test. 
A similar analysis was performed for the mean LDL:HDL-C
ratio. Subjects were also classified as having LDL-choles-
terol levels lower than or higher than 1.5 mmol/l, thus pro-
ducing a 2 × 2 contingency table for which an odds ratio cal-
culation was performed. For the LDL:HDL-C ratio, an odds
ratio was obtained for a partition at LDL:HDL-C ratio = 5.
All statistics were generated using the Statistica™
1984–2000 (Release 5.5) by StatSoft, Inc, USA.
Results
The study group consisted of 115 predominantly Caucasian
[94/115 (82%)] subjects. The rest of the group (21/115 or
18%) was of mixed decent. Gender distribution was 74
(64%) male and 41 (36%) female. The group was also rela-
tively young with the mean age 49.1 years (SD = 10.2).
Table I and Fig. 1 depict the mean values of the different
lipogram components in the study group (n = 115). The
mean total serum cholesterol, triglyceride and LDL choles-
terol levels exceeded the 95th percentile of normal, whereas
the mean serum HDL cholesterol was lower than the 95th
percentile of normal. The study group was divided into two
cohorts, i.e. a subgroup with opacities 47 (41%) and a sub-
group with clear lenses 68 (59%). Analysis of the two sub-
groups (Table I) suggested no difference in the mean age of
the two subgroups (p = 0.07) and no differences in the fol-
lowing lipid parameters of the two subgroups: total serum
cholesterol (p = 0.71); serum LDL cholesterol (p = 0.55);
serum triglycerides (p = 0.81).
TABLE I. MEAN AGE AND SERUM LIPID PROFILES OF
THE SUBGROUPS WITH CLEAR LENSES (n = 68) AND
WITH LENS OPACITIES (n = 47).
Variable Clear lens subgroup Lens opacity subgroup
Mean (± SD) Mean (± SD)
(mmol/l) (mmol/l)
Age (years) 47.3 ± 9.8 50.9 ± 10.6
Total cholesterol 7.33 ± 1.90 7.46 ± 1.82
LDL cholesterol 5.65 ± 1.89 5.84 ± 1.75
HDL cholesterol 1.35 ± 0.35 1.02 ± 0.27
Triglycerides 2.27 ± 1.75 2.34 ± 1.05
Fig. 1. Serum lipid parameters of the study group (n = 115)
compared to the upper limit of normal i.e. 95th percentile
(mmol/l).
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In the lens opacity group the majority [36 (77%)] pre-
sented with cortical opacities. The subgroup with opacities
included all opacities [nuclear 9 (19%), cortical 36 (77%),
and posterior subcapsular 2 (4%)] (Fig. 2).
The HDL cholesterol levels of the two subgroups differed
(Fig. 3). The mean HDL cholesterol level of the subgroup
with clear lenses was 1.35 mmol/l (SD = 0.35 mmol/l)
whereas the mean HDL cholesterol level of the subgroup
with lens opacities was 1.02 mmol/l (SD = 0.27 mmol/l).
This difference of 0.33 mmol/l was highly significant (p <
0.0001). In stratifying the subjects according to HDL-C lev-
els, it was clear that above an HDL-C level of 1.5 mmol/l,
the number of subjects with clear lenses increased. This was
reversed with levels below 1.5 mmol/l (Fig. 3). The odds
ratio (OR) for this shift to happen was 7.33 (95% CI =
2.06–26.10; p = 0.001 for the trend), which predicted that
below an HDL-C level of 1.5 mmol/l, subjects had a seven-
fold higher risk of falling in the lens opacity subgroup than
those with HDL-C levels above 1.5 mmol/l.
Mean LDL:HDL-C ratios were also different between the
two subgroups. The mean LDL:HDL-C ratio in the subgroup
with clear lenses was 4.67 and in the subgroup with lens
opacities, 6.24. This difference of 1.57 was highly signifi-
cant (p = 0.0003). The OR was 2.35 (95% CI = 1.09–5.04; p
= 0.014 for the trend) which implies that subjects with a
LDL:HDL-C ratio above 5 possessed a 2.35 times greater
risk of having lenticular opacities than the group with an
LDL:HDL-C ratio less than 5.
Discussion
In many epidemiological studies, low levels of high-density
(α-) lipoproteins (HDL) have been associated with increased
risk for coronary artery disease (CAD), whereas a high HDL
level (> 1.5 mmol/l) is widely considered to be a negative
risk factor for the development of CAD.6 The observations in
this study also suggest a clear relationship between low lev-
els (< 1.5 mmol/l) of HDL cholesterol and the presence of
lenticular opacities [OR 7.33 (95% CI = 2.06–26.10; p =
0.001)].
An LDL:HDL cholesterol ratio > 5 constitutes another
widely excepted risk factor for the development of CAD.7
Furthermore, the observations in this study group support the
relationship between high serum LDL:HDL cholesterol
ratios (> 5) and lens opacities [OR 2.35 (95% CI =
1.09–5.04; p = 0.014)]. Therefore, the very same serum lipid
component [low HDL (< 1.5 mmol/l) levels and high
LDL:HDL cholesterol ratios (> 5)] that have been identified
as risk factors for CAD are also being implicated as risk fac-
tors for lenticular opacification (mainly of the cortical variety).
The protective effect of HDL-C against CAD partly lies
in the ability of HDL to act as an antioxidant in inhibiting the
formation of oxidised LDL.8 This in turn inhibits the process
of atherosclerosis. The question arises whether the same
mechanism could be involved in the lens.
Oxidative damage has been considered a major factor
involved in cataract formation.9 The lens is chronically
exposed to radiation and upon ageing absorbs increasing
amounts of ultraviolet light.10 Increased production of reac-
tive oxygen species is a feature of most, if not all, human dis-
ease, including cardiovascular disease, cancer and cataract.11
Dietary antioxidants may be especially important in protect-
ing against human diseases associated with free radical dam-
age to cellular DNA, lipids and proteins.12
Experimental work demonstrating the cataractogenic
effect of oxygen and solar radiation, has led to the notion that
intra-ocular generation of certain active species of oxygen
under both photochemical and ambient conditions may initi-
ate a cascade of toxic biochemical reactions, leading ulti-
mately to cataracts and other age-related eye diseases.13-15
Therefore, according to this theory, the ambient oxygen itself
serves as a pathogen after its derivatisation to its more reac-
tive species, commonly referred to as oxygen radicals.
Furthermore, most ocular tissues including the lens, vitre-
ous and aqueous humour contain detectable amounts of pho-
tosensitisers such as riboflavin and kynurenine.16,17 These
photosensitisers can constantly generate superoxide as long
as an appropriate activator (electron donor) is available and
the reaction solution is exposed to light covering the wave-
lengths appropriate for photo-activation.18 These sensitisers
can damage and crosslink lens proteins. The concentration of
Fig. 2. Prevalence of lens opacities (all anatomical sub-
types) in the study group.
Fig. 3. Intra-group stratification of the two subgroups
(with and without opacities) according to HDL choles-
terol levels.
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hydrogen peroxide in the aqueous humour is also remark-
ably high and further increases in cases with cataract, as do
the levels of H2O2 in the lens itself.19,20 The ability of the eye
to deal with these oxygen radicals decreases with age. This
is demonstrated by a measured decrease in the activity of
antioxidant enzymes, particularly superoxide dismutase, as
well as a decrease in glutathione levels in aged cataractous
lenses, accounting for the loss of antioxidant protection.21,22
The impact of free radical toxicity appears far more real
in the eye and specifically the lens than anywhere else in the
body. The transparency of the cornea, aqueous humour, lens
and vitreous humour allows a unique situation for an inces-
sant photochemical generation of oxygen radicals in all the
ocular tissues and the bathing fluids, at least during periods
of photopic vision.
Cholesterol can be oxidised readily by a variety of reac-
tive oxygen species, yielding several products, some of
which possess adverse biological effects.23 The absolute
amount of cholesterol in the lens is not remarkably high, but
is concentrated in lens cell membranes. These membranes
are known to have the highest cholesterol content of any bio-
logical membrane. Cholesterol distribution in the lens
appears to follow an unusual pattern, concentrating in the
pericortical region.24 As an unsaturated lipoprotein, choles-
terol is able to autoxidise. This autoxidation can be initiated
by most of the reactive oxygen species. The high concentra-
tion of cholesterol in lens membranes may provide the most
important substrate for oxidation. Girao et al.25 (1998) were
the first to show that oxysterols (the products of lipid oxida-
tion) accumulate in human cataracts.25 Significant oxidation
of cholesterol may well result in cell injury, at least partially
compatible with the damage associated with cataract forma-
tion.
It has been suggested in different contexts that cholesterol
may act as an antioxidant.26 The high concentrations of chol-
esterol in the lens would enable it to perform a role in the
lens comparable to that ascribed for albumin in the plasma.27
The lens could in this regard be considered to be ‘the albu-
min of the eye’. Girao et al.28 (1999) were the first to propose
that cholesterol may act as an antioxidant in the lens;28 in par-
ticular HDL cholesterol, because of its well-known ability to
protect the body from the oxidative damage found in cardio-
vascular disease.29 Girao et al.’s initial study was designed to
establish whether HDL cholesterol acts as an antioxidant in
the bovine lens.25 They found that oxidation of bovine lens
membrane resulted in the production of lipid hydroperox-
ides, consumption of endogenous vitamin E and formation
of cholesterol oxides and concluded that HDL-C presents
important characteristics generally ascribed to an antioxidant
molecule.
The lens cell membrane has the highest concentration of
cholesterol in the body. The cholesterol-to-phospholipid
(C:P) mole ratio in the lens ranges between 1 and 4. In con-
trast, plasma membranes of typical eukaryotic cells have C:P
mole ratios between 0.5 and 1.0. The only other known
membrane with C:P mole ratios comparable to the lens are
diseased, atherosclerotic, vascular smooth muscle cell mem-
branes. Adequate vision relies on lens transparency, which in
turn is severely affected by any change in the lens membrane
structure or composition. Altering of the lens lipid composi-
tion or structure may cause lenticular opacities. These lens
lipids are prone to oxidative damage. HDL cholesterol may
indeed act as an antioxidant, protecting the lens against this
oxidative onslaught. Cholesterol may therefore be regarded
both as a bad (oxidant) and a good molecule (antioxidant) in
the lens.
The proposed mechanism by which photopic vision, via
both a photochemical and non-photochemical pathway, pro-
duces free radicals is summarised in Fig. 4. Normal mecha-
nisms exist by which these reactive oxygen species are inac-
tivated, but should these mechanisms fail, cytotoxicity
results either directly as damage to cellular DNA, lipids and
protein, or indirectly via the oxidation of cholesterol and cho-
lesterol oxidation products. A lack of adequate anti-oxidants,
including HDL-cholesterol, will result in lens damage by the
reactive oxygen species produced by daily photopic vision.
Conclusions
Low HDL-C levels (< 1.5 mmol/l) and an elevated
LDL:HDL ratio (> 5) present significant cataractogenic risk
factors, whereas the lens is protected by high HDL-C levels
(> 1.5 mmol/l) and low LDL:HDL ratios (< 5) in the dys-
lipidaemic patient. These are exactly the same risk factors
that have often been implicated in the development of ather-
osclerotic circulatory disease. It is true that low HDL levels
can frequently be linked to a genetic predisposition but HDL
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Fig. 4. Schematic summary of proposed mechanism by
which photopic vision leads to the production of free
radicals, cholesterol oxidation and lens opacities.
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levels can also be reduced by other factors. These include
obesity, sedentary lifestyle, cigarette use, diabetes mellitus,
uraemia, nephrotic syndrome, and several drugs like thiazide
diuretics, retinoids, beta-blockers, androgenic steroids and
most progestational drugs.30 Could human age-related
cataract therefore be regarded as a preventable condition
because of this association of low HDL levels with lifestyle
factors? Because these factors are potentially modifiable by
lifestyle changes, these observations may prove important,
as the modification of these parameters could constitute an
effective mode of prevention or retardation in a subgroup of
patients who develop cataracts at an early age.
We express our gratitude to Professor Stefan Maritz of the South
African Medical Research Council and Mr Jean Dommisse,
Department of Statistics, University of Stellenbosch for invaluable
assistance with the statistical analysis of data.
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